If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

The global retinitis pigmentosa market, valued at $11.31 billion in 2024, is expected to grow to $25.87 billion by 2034, driven by gene therapy advancements, aging populations, and strategic ...

Retinitis pigmentosa (RP) is a term for a group of eye diseases that can lead to loss of sight. What they have in common are specific changes your doctor sees when they look at your retina – a ...

"Bumping" into objects that appear to "come out of nowhere" could be an early sign of retinitis pigmentosa, a sight condition.

Urticaria pigmentosa is a rash, most common in children and young adults, characterized by reddish-brown, gray, or purple lesions. Learn about its causes, symptoms, diagnosis, treatment, and more.

Retinitis Pigmentosa This is a hereditary eye disease in which photoreceptors (light-detecting cells) on the retina begin to degenerate and cause a gradual decline in vision.

Newer techniques using nanoparticles are less invasive, but some need bright visible light, which can harm any remaining ...

New research shows that retinal neurons can rewire to preserve vision in retinitis pigmentosa, a genetic disease causing blindness.

Advances in Gene-based Therapies for RP The high degree of genetic heterogeneity of RP has led to the exploration of multiple approaches to therapy for this group of disorders. Gene therapy ...

The global retinitis pigmentosa market, valued at $11.31 billion in 2024, is expected to grow to $25.87 billion by 2034, driven by gene therapy advancements, aging populations, and strategic industry ...

Chitra Kannabiran, PhD, Kallam Anji Reddy Molecular Genetics Laboratory, Hyderabad Eye Research Foundation, Champalimaud Translational Centre, LV Prasad Eye Institute, Hyderabad 500 034, India ...